ExtendicareEXETF 76 Interest Coverage is 8.42 as of Mar. 2026, which is 288% above its 10-year median of 2.17. GuruFocus rates EXETF with a GF Score™ of 76/100 and a GF Value™ of $10.02 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 453 Healthcare Providers & Services companies, Extendicare ranks worse than 50.99% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Extendicare's
Operating Income
for the
three
months ended in Mar. 2026 was $31 Mil. Extendicare's Interest Expense for the
three
months ended in Mar. 2026 was $-4 Mil.
Extendicare's interest coverage for the quarter that ended in Mar. 2026 was 8.42.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Extendicare's Interest Coverage or its related term are showing as below:
EXETF'
s Interest Coverage Range Over the Past 10 Years
Min: 1.19 Med: 2.17 Max: 7.78
Current: 7.78
EXETF's Interest Coverage is ranked worse than 50.99% of 453
companies
in the Healthcare Providers & Services industry
Industry Median: 7.98
vs EXETF: 7.78
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Extendicare Interest Coverage Related Terms
Extendicare Interest Coverage Historical Data
* Premium members only.
The historical data trend for Extendicare's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
EXETF vs HCA, THC, DVA: Interest Coverage Comparison
For the Medical Care Facilities subindustry, Extendicare's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Extendicare Interest Coverage vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Extendicare's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Extendicare's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Extendicare (EXETF) has a Interest Coverage of 8.42 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Extendicare and its competitors. This is 288% above median its historical median of 2.17. Over the past decade, Extendicare's Interest Coverage has ranged from 1.19 to 7.78. According to the industry distribution chart, Extendicare ranks #231 out of 453 companies in the Healthcare Providers & Services industry, placing it in the top 51%.
Is Extendicare's Interest Coverage too high?
Extendicare's current Interest Coverage of 8.42 is 288% above median its 10-year median of 2.17. Over the past 10 years, this metric has ranged from a low of 1.19 to a high of 7.78. The Healthcare Providers & Services industry median Interest Coverage is 7.98. Extendicare's value of 8.42 is 5.5% above this industry median. Based on the distribution chart, Extendicare ranks #231 out of 453 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Extendicare has a GF Score™ of 76/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Extendicare's Interest Coverage compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Extendicare ranks #231 out of 453 companies for Interest Coverage. This places Extendicare in the lower half of its industry. The industry median Interest Coverage is 7.98. Extendicare's value of 8.42 is 5.5% above this benchmark. Historically, Extendicare's own Interest Coverage has ranged from 1.19 to 7.78 over the past decade. While the company's 10-year median is 2.17 vs. the industry median of 7.98, Extendicare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Healthcare Providers & Services company?
The median Interest Coverage among Healthcare Providers & Services companies is 7.98, based on 453 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Extendicare's current Interest Coverage of 8.42 is 5.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Extendicare and its competitors. For the Healthcare Providers & Services industry, the median Interest Coverage is 7.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Extendicare's current Interest Coverage is 8.42, which is 288% above median its own 10-year median of 2.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Extendicare stock overvalued right now?
Based on GuruFocus' analysis, Extendicare (EXETF) is currently considered Significantly Overvalued. The stock's GF Value™ is $10.02, compared to a current price of $24.63 — trading 145.8% above its estimated fair value. The current Interest Coverage is 8.42, which is 288% above median its 10-year median of 2.17 and 5.5% above the Healthcare Providers & Services industry median of 7.98. Extendicare's overall GF Score™ is 76/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Extendicare (EXETF), the current Interest Coverage is 8.42 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Extendicare (EXETF) Overvalued in 2026?
Based on GuruFocus' analysis, Extendicare stock appears to be overvalued.
The current stock price of $24.63 is trading 145.8% above its estimated GF Value™ of $10.02.
GuruFocus considers Extendicare to be Significantly Overvalued.
Key valuation signals for EXETF:
Interest Coverage: 8.42 (288% above median its 10-year median of 2.17)
GF Value™: $10.02 vs. price of $24.63 (145.8% above fair value)
Industry Position: 5.5% above the Healthcare Providers & Services median (#231 of 453)
No single metric tells the full story. See the EXETF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Extendicare Inc is a senior care provider in Canada, focused on long-term care and home health care. The has three main business segments: Long-term Care (LTC), Home Health Care, and Managed Services. The Long-term Care segment, operating under the Extendicare brand, represents 53 owned homes in Ontario, Alberta and Manitoba. The Home Health Care segment, operating under the ParaMed brand, provides home health care services annually in Ontario, Alberta, Manitoba and Nova Scotia. The Managed Services segment, operating under the Extendicare Assist and SGP Purchasing Partner Network brands, provides management, consulting and group purchasing services to other care providers across Canada. The majority of the company's revenue is derived from the Long-term Care segment.
76GF Score
Get the complete analysis for EXETF
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
EXETF has been successfully added to your 
